-
As the 2024 election approaches, Donald Trump has proposed significant tax cuts aimed at working-class voters, including eliminating taxes on overtime pay and restoring the state and local tax (SALT) deduction. These proposals have raised concerns about their fiscal implications and potential benefits for high-income earners, with contrasting views emerging from analysts and political figures.
-
As the Medicare enrollment period approaches, significant changes are expected for Medicare Advantage plans. Humana's stock has plummeted due to downgrades in its quality ratings, affecting millions of beneficiaries. Insurers are also scaling back offerings amid rising costs and political pressures ahead of the presidential election.
-
As the 2024 presidential election approaches, Kamala Harris ramps up her media presence with a series of interviews, while Donald Trump declines to participate in key media events. Both candidates are vying for crucial demographics as polling shows a tight race ahead of the November 5 election.
-
As the election approaches, analyses reveal stark differences between Trump's and Harris' tax proposals. Trump's plans could add up to $15 trillion to the national debt, while Harris' may increase it by $3.5 trillion, raising questions about fiscal responsibility and the impact on various income groups.
-
GlaxoSmithKline (GSK) has reached a $2.2 billion settlement to resolve litigation from approximately 80,000 claimants in the U.S. who alleged that its heartburn drug Zantac caused cancer. The settlement covers 93% of pending cases and does not involve an admission of liability by GSK.